Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lifecore Biomedical, Inc. - Common Stock
(NQ:
LFCR
)
5.610
-0.420 (-6.97%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
259,802
Open
5.960
Bid (Size)
5.480 (4)
Ask (Size)
7.020 (1)
Prev. Close
6.030
Today's Range
5.495 - 5.980
52wk Range
4.470 - 11.46
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ROSEN, LEADING INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LFCR
August 02, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR)
August 02, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
Performance
YTD
-12.07%
-12.07%
1 Month
+13.79%
+13.79%
3 Month
-12.21%
-12.21%
6 Month
-13.56%
-13.56%
1 Year
-45.59%
-45.59%
More News
Read More
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Lifecore Biomedical, Inc. (LFCR) Investors
August 01, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Lifecore Biomedical, Inc. (LFCR) Investors
July 31, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
LIFECORE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Lifecore Biomedical, Inc. and Encourages Investors to Contact the Firm
July 31, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Lifecore Biomedical, Inc. (LFCR) Investors
July 31, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) INVESTOR ALERT: Investors With Large Losses in Lifecore Biomedical Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
July 31, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
July 31, 2024
From
Schall Law
Via
GlobeNewswire
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Lifecore Biomedical, Inc. Investors
July 30, 2024
From
Kirby McInerney LLP
Via
Business Wire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
July 30, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
July 30, 2024
From
The Schall Law Firm
Via
Business Wire
LFCR INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
July 30, 2024
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Rosen Law Firm Urges Lifecore Biomedical, Inc. (NASDAQ: LFCR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
July 30, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
Lifecore Biomedical Announces Cooperation Agreement with 22NW
July 01, 2024
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 22, 2024
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Completes Incremental Liquidity Initiatives
May 16, 2024
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
May 14, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
May 14, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
May 10, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
May 10, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
May 08, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
May 08, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
May 07, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
ROSEN, A LEADING NATIONAL FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
May 03, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, A LEADING NATIONAL FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
May 03, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.